The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations

Cellular Immunology

Volumn 228, Issue 1, 2004, Pages 42-53

  Nixon, Jamee C ^a,b   Rajaiya, Jaya B ^b   Ayers, Neil ^b   Evetts, Seth ^b   Webb, Carol F ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

B cell; Bright; BTK; XLA

Indexed keywords

B LYMPHOCYTE DIFFERENTIATION FACTOR; BRUTON TYROSINE KINASE; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRIGHT; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; DNA BINDING MOTIF; ENZYME ACTIVITY; HUMAN VERSUS ANIMAL COMPARISON; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; X LINKED AGAMMAGLOBULINEMIA;

B-LYMPHOCYTE SUBSETS; BASE SEQUENCE; BINDING SITES; CELL LINE, TRANSFORMED; CONSENSUS SEQUENCE; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION; GERMINAL CENTER; HUMANS; ONCOGENES; PROTEIN-TYROSINE KINASES; STEM CELLS; TISSUE DISTRIBUTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 2942596153     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.03.004     Document Type: Article

References (36)

1. Herrscher R.F., Kaplan M.H., Lelsz D.L., Das C., Scheuermann R., Tucker P.W. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev. 9:1995;3067-3082
2. Gregory S.L., Kortschak R.D., Kalionis B., Saint R. Characterization of the dead ringer gene identifies a novel, highly conserved family of sequence-specific DNA-binding proteins. Mol. Cell. Biol. 16:1996;792-799
3. Treisman J.E., Luk A., Rubin G.M., Heberlein U. eyelid antagonizes wingless signaling during Drosophila development and has homology to the Bright family of DNA-binding proteins. Genes Dev. 11:1997;1949-1962
4. Fattaey A.R., Helin K., Dembski M.S., et al. Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene. 8:1993;3149-3156
5. Numata S., Claudio P.P., Dean C., Giordano A., Croce C.M. Bdp, a new member of a family of DNA-binding proteins, associates with the retinoblastoma gene product. Cancer Res. 59:1999;3741-3747
6. Peterson C.L., Herskowitz I. Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription. Cell. 68:1992;573-583
7. Burns L.G., Peterson C.L. The yeast SWI-SNF complex facilitates binding of a transcriptional activator to nucleosomal sites in vivo. Mol. Cell. Biol. 17:1997;4811-4819
8. Dallas P.B., Pacchione S., Wilsker D., Bowrin V., Kobayashi R., Moran E. The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity. Mol. Cell. Biol. 20:2000;3137-3146
9. Webb C.F., Das C., Eaton S., Calame K., Tucker P.W. Novel protein-DNA interactions associated with increased immunoglobulin transcription in response to antigen plus interleukin-5. Mol. Cell. Biol. 11:1991;5197-5205
10. Webb C.F., Smith E.A., Medina K.L., Buchanan K.L., Smithson G., Dou S. Expression of Bright at two distinct stages of B lymphocyte development. J. Immunol. 160:1998;4747-4754
11. Webb C.F., Das C., Coffman R.L., Tucker P.W. Induction of immunoglobulin μmRNA in a B cell transfectant stimulated with interleukin-5 and a T-dependent antigen. J. Immunol. 143:1989;3934-3939
12. ′ of an immunoglobulin heavy chain variable region gene Mol. Cell. Biol. 11:1991;5206-5211
13. Wang Z., Goldstein A., Zong R.-T., Lin D., Neufeld E.J., Scheuermann R.H., Tucker P.W. Cux/CDP homeoprotein is a component of NF-μNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the Bright transcription activator. Mol. Cell. Biol. 19:1999;284-295
14. Webb C., Zong R.-T., Lin D., et al. Differential regulation of immunoglobulin gene transcription via nuclear matrix-associated regions. Cold Spring Harbor Symp. Quant. Biol. LXIV:1999;109
15. Webb C.F., Yamashita Y., Ayers N., Evetts S., Paulin Y., Conley M.E., Smith E.A. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J. Immunol. 165:2000;6956-6965
16. Conley M.E., Parolini O., Rohrer J., Campana D. X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene. Immunol. Rev. 138:1994;5-21
17. Satterthwaite A., Witte O. Genetic analysis of tyrosine kinase function in B cell development. Annu. Rev. Immunol. 14:1996;131-154
18. Guo B.C., Kato R.M., Garcia-Lloret M., Wahl M.I., Rawlings D.J. Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex. Immunity. 13:2000;243-253
19. 2+ following B-cell receptor activation. EMBO J. 17:1998;1973-1985
20. Fruman D.A., Satterthwaite A.B., Witte O.N. Xid -like phenotypes: A B cell signalosome takes shape. Immunity. 13:2000;1-3
21. Mohamed A.J., Vargas L., Nore B.F., Backesjo C.M., Christensson B., Smith C.I. Nucleocytoplasmic shuttling of Bruton's tyrosine kinase. J. Biol. Chem. 275:2000;40614-40619
22. Kortschak R.D., Reimann H., Zimmer M., Eyre H.J., Saint R., Jenne D.E. The human dead ringer bright homolog, DRIL1: cDNA cloning, gene structure, and mapping to D19S886, a marker on 19p13.3 that is strictly linked to the Peutz-Jeghers syndrome. Genomics. 51:1998;288-292
23. Webb C.F., Tucker P.W., Dowton S.B. Expression and sequence analyses of serum amyloid A in the Syrian hamster. Biochemistry. 28:1989;4785-4790
24. Medina K.L., Garrett K.P., Thompson L.F., Rossi M.I., Payne K.J., Kincade P.W. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat. Immunol. 2:2001;718-724
25. Pascual V., Liu Y.-J., Magalski A., de Bouteiller O., Banchereau J., Capra J.D. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180:1994;329-339
26. H promoters in vitro. J. Immunol. 155:1995;4270-4277
27. + B cell line. J. Immunol. 160:1998;2145-2157
28. Lozzio B.B., Lozzio C.B., Bamberger E.G., Feliu A.S. A multipotential leukemia cell line (K-562) of human origin. Proc. Soc. Exp. Biol. Med. 166:1981;546-550
29. Rossi M.I., Medina K.L., Garrett K., et al. Relatively normal human lymphopoiesis but rapid turnover of newly formed B cells in transplanted nonobese diabetic/SCID mice. J. Immunol. 167:2001;3033-3042
30. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511
31. Klein U., Tu Y.H., Stolovitzky G.A., et al. Transcriptional analysis of the B cell germinal center reaction. Proc. Natl. Acad. Sci. USA. 100:2003;2639-2644
32. Numata S., Claudio P.P., Dean C., Giordano A., Croce C.M. Bdp, a new member of a family of DNA-binding proteins, associates with the retinoblastoma gene product. Cancer Res. 59:1999;3741-3747
33. Novina C.D., Kumar S., Bajpai U., Cheriyath V., Zhang K.M., Pillai S., Wortis H.H., Roy A.L. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase. Mol. Cell. Biol. 19:1999;5014-5024
34. Cheriyath V., Novina C.D., Roy A.L. TFII-I regulates Vβ promoter activity through an initiator element. Mol. Cell. Biol. 18:1998;4444-4454
35. Kouro T., Nagata K., Takaki S., et al. Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition. Int. Immunol. 13:2001;485-493
36. Middendorp S., Dingjan G.M., Hendriks R.W. Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice. J. Immunol. 168:2002;2695-2703